Mar­ry­ing pre­ci­sion med and AI, Groupon co-founder Er­ic Lefkof­sky takes to­tal haul for his an­a­lyt­ics firm over the $1B line

The pan­dem­ic has tak­en Tem­pus — the com­pa­ny Groupon co-founder Er­ic Lefkof­sky launched to bring ar­ti­fi­cial in­tel­li­gence to physi­cians and re­searchers fo­cused on pre­ci­sion med­i­cine — in quite a few un­ex­pect­ed turns.

Not on­ly did it launch ef­forts to help doc­tors in their core field of can­cer adapt to new ways of work­ing, it al­so made a de­ci­sion to ex­pand in­to in­fec­tious dis­eases (start­ing with Covid-19), while dou­bling down on de­pres­sion and car­di­ol­o­gy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER